7 assets in Trigeminal Autonomic Cephalalgia

Therapeutic assets addressing Trigeminal Autonomic Cephalalgia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer Trigeminal Autonomic Cephalalgia	Beijing Tiantan Hospital	P2	B (57)
Marcaine Trigeminal Autonomic Cephalalgia	Stanford University	P2	CCC (53)
AIR Trigeminal Autonomic Cephalalgia	The University of Texas Health Science Center, Houston	P1	CC (43)
Capsaicin Trigeminal Autonomic Cephalalgia	The University of Texas Health Science Center, Houston	P1	CC (43)
Oxygen Trigeminal Autonomic Cephalalgia	The University of Texas Health Science Center, Houston	P1	CC (43)